Innoveren Scientific (Innoveren Scientific) Growth Rank : 0 (As of Jun. 04, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Innoveren Scientific Growth Rank?

Innoveren Scientific has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Innoveren Scientific Growth Rank Related Terms

Thank you for viewing the detailed overview of Innoveren Scientific's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Innoveren Scientific (Innoveren Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innoveren Scientific Inc (OTCPK:IVRN) » Definitions » Growth Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

2202 N West Shore Boulevard, Suite 200, Tampa, FL, USA, 33607

Website

https://www.hcyte.com

Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.

Executives

Fwhc Holdings, Llc	10 percent owner	1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Hoa Capital Llc	10 percent owner	1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Farrior J Rex Iii	10 percent owner	1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Fwhc Bridge Friends, Llc	10 percent owner	1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Raymond Monteleone	director	201 E KENNEDY BLVD, STE 700, TAMPA FL 33602
Jeremy Daniel	officer: Chief Financial Officer	201 E KENNEDY AVE, STE 700, TAMPA FL 33602
Robert Smith Greif	officer: President and C.E.O.	19 MAY STREET, NEEDHAM MA 02492
Cfrs Investments, Llc	10 percent owner	2903 W VILLA ROSA PARK, TAMPA FL 33611
Frederick J Lynch	10 percent owner	C/O MASONITE INTERNATIONAL CORPORATION, 201 NORTH FRANKLIN ST., SUITE 300, TAMPA FL 33602
Fwhc Bridge, Llc	10 percent owner	334 EAST LAKE ROAD, SUITE 176, PALM HARBOT FL 34685
Todd R Wagner	10 percent owner	3385 OLD KEYSTONE ROAD, TARPON SPRINGS FL 34688
Michael Yurkowsky	director	2380 OLD MILTON PARKWAY, ALPHARETTA GA 30009
William E Horne	director, officer: Chief Executive Officer	201 EAST KENNEDY BLVD, SUITE 700, TAMPA FL 33602
Jon Mogford	director	714 PLUM HOLLOW DRIVE, COLLEGE STATION TX 77845
John C Thomas	director	8601 SIX FORKS ROAD, SUITE 160, RALEIGH NC 27615